The Evaluation of Postmarketing Adverse Drug Experience Reports at FDA: Part I

• 1 October 1993
• journal article
• research article
• Published by Springer Nature in Drug Information Journal
• Vol. 27  (4) , 1159-1165
• https://doi.org/10.1177/009286159302700433

Abstract

Keywords

• SPONTANEOUS REPORTING SYSTEM
• ADVERSE DRUG EXPERIENCE
• MEDICAL MODEL